blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2369936

EP2369936 - COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LENS FIBROTIC DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.11.2018
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  22.12.2017
FormerGrant of patent is intended
Status updated on  31.07.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Lankenau Institute for Medical Research
100 East Lancaster Avenue
Wynnewood, PA 19096 / US
For all designated states
Thomas Jefferson University
1020 Walnut Street
Philadelphia, PA 19107 / US
[2012/19]
Former [2011/40]For all designated states
Lankenau Institute for Medical Research
100 East Lancaster Avenue
Wynnewood, PA 19096 / US
Inventor(s)01 / MENKO, Allyn, Sue
205 Standish Road
Merion PA 19066 / US
02 / GEORGE-WEINSTEIN, Mindy
227 Hemlock Road
Wynnewood PA 19096 / US
03 / WALKER, Janice, L.
235A Bainbridge Street
Philadelphia PA 19147 / US
04 / GERHART, Jacquelyn
244 Rockglen Road
Wynnewood PA 19096 / US
 [2011/40]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2018/04]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2013/37]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham
NG1 5GG / GB
Former [2011/40]Didmon, Mark, et al
Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date09831240.804.12.2009
[2018/04]
WO2009US66859
Priority number, dateUS20080119750P04.12.2008         Original published format: US 119750 P
[2011/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010065920
Date:10.06.2010
Language:EN
[2010/23]
Type: A1 Application with search report 
No.:EP2369936
Date:05.10.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 10.06.2010 takes the place of the publication of the European patent application.
[2011/40]
Type: B1 Patent specification 
No.:EP2369936
Date:24.01.2018
Language:EN
[2018/04]
Search report(s)International search report - published on:US10.06.2010
(Supplementary) European search report - dispatched on:EP07.12.2012
ClassificationIPC:A01N63/02, A61K39/395
[2011/40]
CPC:
C07K16/28 (EP,US); A61P27/02 (EP); A61P27/12 (EP);
A61P43/00 (EP); C07K16/30 (EP,US); A61K2039/505 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2018/04]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND PRÄVENTION VON FIBROTISCHEN LINSENERKRANKUNGEN[2011/40]
English:COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LENS FIBROTIC DISEASES[2011/40]
French:COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT PROPHYLACTIQUE ET THÉRAPEUTIQUE DE MALADIES FIBROTIQUES DU CRISTALLIN[2011/40]
Entry into regional phase01.07.2011National basic fee paid 
01.07.2011Search fee paid 
01.07.2011Designation fee(s) paid 
01.07.2011Examination fee paid 
Examination procedure01.07.2011Examination requested  [2011/40]
05.07.2013Amendment by applicant (claims and/or description)
06.05.2015Despatch of a communication from the examining division (Time limit: M06)
06.11.2015Reply to a communication from the examining division
21.06.2017Cancellation of oral proceeding that was planned for 29.06.2017
29.06.2017Date of oral proceedings (cancelled)
01.08.2017Communication of intention to grant the patent
13.11.2017Fee for grant paid
13.11.2017Fee for publishing/printing paid
13.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.05.2015
Opposition(s)25.10.2018No opposition filed within time limit [2019/01]
Fees paidRenewal fee
12.12.2011Renewal fee patent year 03
11.12.2012Renewal fee patent year 04
12.12.2013Renewal fee patent year 05
11.12.2014Renewal fee patent year 06
10.12.2015Renewal fee patent year 07
13.12.2016Renewal fee patent year 08
12.12.2017Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.12.2009
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
MK24.01.2018
NL24.01.2018
PL24.01.2018
PT24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
[2020/31]
Former [2020/30]HU04.12.2009
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
NL24.01.2018
PL24.01.2018
PT24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2020/27]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
NL24.01.2018
PL24.01.2018
PT24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2020/16]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2019/40]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2019/13]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/52]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/51]AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SK24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/50]AT24.01.2018
CY24.01.2018
CZ24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
SK24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/49]AT24.01.2018
CY24.01.2018
EE24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
RO24.01.2018
SE24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/47]AT24.01.2018
CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
IT24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
SE24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/40]AT24.01.2018
CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
SE24.01.2018
BG24.04.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/39]AT24.01.2018
CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
NL24.01.2018
PL24.01.2018
SE24.01.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/38]AT24.01.2018
CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
NL24.01.2018
PL24.01.2018
NO24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/37]CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
NL24.01.2018
PL24.01.2018
NO24.04.2018
GR25.04.2018
Former [2018/36]CY24.01.2018
ES24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
NL24.01.2018
PL24.01.2018
NO24.04.2018
Former [2018/35]CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
NL24.01.2018
NO24.04.2018
Former [2018/34]FI24.01.2018
LT24.01.2018
NL24.01.2018
NO24.04.2018
Documents cited:Search[XI]WO2006128152  (UNIV JEFFERSON [US], et al) [X] 1-6,11-13 * the whole document * [I] 7,14;
 [X]WO2004072117  (PHARMACIA CORP [US], et al) [X] 1-7,11-14 * the whole document *;
 [X]  - J. GERHART ET AL, "MyoD-positive epiblast cells regulate skeletal muscle differentiation in the embryo", THE JOURNAL OF CELL BIOLOGY, (20060101), vol. 175, no. 2, doi:10.1083/jcb.200605037, ISSN 0021-9525, pages 283 - 292, XP055042620 [X] 3-10,12-15 * the whole document *

DOI:   http://dx.doi.org/10.1083/jcb.200605037
 [X]  - STRONY R ET AL, "NeuroM and MyoD are expressed in separate subpopulations of cells in the pregastrulating epiblast", GENE EXPRESSION PATTERNS, ELSEVIER, AMSTERDAM, NL, vol. 5, no. 3, ISSN 1567-133X, (20050201), pages 387 - 395, (20050201), XP027680294 [X] 3-10,12-15 * the whole document *
 [A]  - IANG Q ET AL, "EGF-INDUCED CELL MIGRATION IS MEDIATED BY ERK AND PI3K/AKT PATHWAYS IN CULTURED HUMAN LENS EPITHELIAL CELLS", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, MARY ANN LIEBERT, INC., NEW YORK, NY, US, (20060101), vol. 22, no. 2, doi:10.1089/JOP.2006.22.93, ISSN 1080-7683, pages 93 - 102, XP009072395 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1089/jop.2006.22.93
 [IA]  - NAGAMOTO TOSHIYUKI ET AL, "Alpha-smooth muscle actin expression in cultured lens epithelial cells", IOVS, (200004), no. 5, pages 1122 - 1129, XP009164265 [I] 1-8,10-14 * the whole document * [A] 9,15
 [IA]  - SCHMITT-GRAFF A ET AL, "APPEARANCE OF ALPHA SMOOTH MUSCLE ACTIN IN HUMAN EYE LENS CELLS OF ANTERIOR CAPSULAR CATARACT AND IN CULTURED BOVINE LENS-FORMING CELLS", DIFFERENTIATION, (1990), vol. 43, no. 2, ISSN 0301-4681, pages 115 - 122, XP002687923 [I] 1-8,10-14 * the whole document * [A] 9,15

DOI:   http://dx.doi.org/10.1111/j.1432-0436.1990.tb00437.x
 [XI]  - J. L. WALKER ET AL, "Activation of Src Kinases Signals Induction of Posterior Capsule Opacification", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, (20070501), vol. 48, no. 5, doi:10.1167/iovs.06-1059, ISSN 0146-0404, pages 2214 - 2223, XP055042502 [X] 1-6,8,11-13 * the whole document * [I] 7,14

DOI:   http://dx.doi.org/10.1167/iovs.06-1059
 [XI]  - ZHOU J ET AL, "SRC KINASE ACTIVATION INDUCES FORMATION OF LENS OPACITIES THROUGH A PATHWAY", ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, XX, XX, (20030508), vol. 2003, XP009072433 [X] 1-6,8,11-13 * the whole document * [I] 7,14
 [XI]  - ZHOU J ET AL, "INHIBITION OF SRC FAMILY KINASES BLOCKS FORMATION OF CORTICAL CATARACTS IN CULTURED CHICK EMBRYO LENSES", ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, XX, XX, (20020510), vol. 2002, XP009072432 [X] 1-6,8,11-13 * the whole document * [I] 7,14
 [XI]  - WORMSTONE I M ET AL, "IDENTIFICATION OF SIGNALLING PATHWAYS INVOLVED IN TGFB2 INDUCED MATRIX CONTRACTION OF HUMAN LENS CELLS", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, US, (20050501), vol. 46, no. SUPPL. S, ISSN 0146-0404, XP009072393 [X] 1-6,8,11-13 * the whole document * [I] 7,14
 [XI]  - WOLFF I M ET AL, "MIGRATION OF LENS EPITHELIAL CELLS ON THE POSTERIOR LENS CAPSULE IS BLOCKED BY INHIBITION OF SRC FAMILY KINASES", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, US, (20050501), vol. 46, no. SUPPL. S, ISSN 0146-0404, page B421), XP009072394 [X] 1-6,8,11-13 * the whole document * [I] 7,14
 [A]  - FRIEDLANDER M, "Fibrosis and diseases of the eye", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (20070301), vol. 117, no. 3, doi:10.1172/JCI31030, ISSN 0021-9738, pages 576 - 586, XP008114654 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI31030
 [IP]  - GERHART J ET AL, "Noggin producing, MyoD-positive cells are crucial for eye development", DEVELOPMENTAL BIOLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 336, no. 1, ISSN 0012-1606, (20091201), pages 30 - 41, (20090922), XP026802168 [IP] 1-15 * the whole document *
 [T]  - WALKER JANICE L ET AL, "Unique precursors for the mesenchymal cells involved in injury response and fibrosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (201008), vol. 107, no. 31, ISSN 0027-8424, pages 13730 - 13735, XP002687924 [T] * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0910382107
International search[Y]US6180357  (YOUNG DAVID S F [CA], et al);
 [Y]  - GERHART ET AL., "MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle", THE JOURNAL OF CELL BIOLOGY, (20011029), vol. 155, no. 3, doi:doi:10.1083/jcb.200105139, pages 381 - 391, XP055042480

DOI:   http://dx.doi.org/10.1083/jcb.200105139
 [Y]  - SRINIVASAN ET AL., "Lens-specific Expression of Transforming Growth Factor B1 in Transgenic Mica Causes Anterior Subcapsular Cataracts", J. CLIN. INVEST., (199802), vol. 101, no. 3, pages 625 - 634
by applicantWO2006128152
 WO2004072117
 EP0404097
 WO9311161
    - GERHART et al., J Cell Biol., (20011029), vol. 155, no. 3, pages 381 - 392
    - SRINIVASAN et al., J Clin Invest, (19980201), vol. 101, no. 3, pages 625 - 634
    - GERHART et al., J Cell Biol., (20061023), vol. 175, no. 2, pages 283 - 292
    - STRONY et al., Gene Expression Patterns, (20050201), vol. 5, no. 3, pages 387 - 395
    - NAGAMOTO et al., Invest Ophthalmol Vis Sci., (20000400), vol. 41, no. 5, pages 1122 - 9
    - SCHMITT-GRAFF et al., Differentiation, (19900400), vol. 43, no. 2, pages 115 - 22
    - WALKER et al., Invest Ophthalmol Vis Sci., (20070500), vol. 48, no. 5, pages 2214 - 23
    - WOLFF et al., Investigative Ophthalmology & Visual Science, (20050500), vol. 46, page 2868
    - GERHART et al., Dev Biol., (20091201), vol. 336, no. 1, pages 30 - 41
    - WALKER et al., Proc Natl Acad Sci U S A., (20100803), vol. 107, no. 31, pages 13730 - 5
    - CHAKRAVARTY et al., PNAS, (20080000), vol. 105, pages 8697 - 8702
    - CHO et al., Clin. Cancer Res., (20080000), vol. 14, pages 1310 - 1316
    - Remington's Pharmaceutical Sciences, 18th ed., Mack Publishing Co., (19900000), pages 1435 - 1712
    - TERSKIKH et al., PNAS, (19970000), vol. 94, pages 1663 - 1668
    - HOLLIGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448
    - E.W. MARTIN, Remington's Pharmaceutical Sciences, Mack Publishing Co.
    - WALKER et al., Invest. Ophthalmol. Vis. Sci., (20070000), vol. 48, pages 2214 - 23
    - GERHART et al., J. Cell Biol., (20010000), vol. 155, pages 381 - 391
    - GERHART et al., J. Cell Biol., (20040000), vol. 164, pages 739 - 746
    - STRONY et al., Gene Expr. Patterns, (20050000), vol. 5, pages 387 - 395
    - GERHART et al., Biol. Proced. Online, (20040000), vol. 6, pages 149 - 156
    - DECHESNE et al., Mol. Cell. Biol., (19940000), vol. 14, pages 5474 - 5486
    - STRONY et al., Gene Exp. Patterns, (20050000), vol. 5, pages 387 - 395
    - GERHART et al., J. Cell Biol., (20070000), vol. 178, pages 649 - 660
    - GERHART et al., J. Cell Biol., (20060000), vol. 175, pages 283 - 292
    - GERHART et al., Biol. Proc. Online, (20080000), vol. 10, pages 74 - 82
    - RADISKY et al., J. Cell Biochem., (20070000), vol. 101, pages 830 - 9
    - EYDEN, B., J. Cell Mol. Med., (20080000), vol. 12, pages 22 - 37
    - POLYAK et al., Nat. Rev. Cancer, (20090000), vol. 9, pages 265 - 73
    - BAUM et al., Semin. Cell Dev. Biol., (20080000), vol. 19, pages 294 - 308
    - LEE et al., J. Cell Biol., (20060000), vol. 172, pages 973 - 81
    - BELLAIRS, R., Anat Embryol (Berl, (19860000), vol. 174, pages 1 - 14
    - GEORGE-WEINSTEIN et al., Dev. Biol., (19960000), vol. 173, pages 279 - 91
    - GERHART et al., J. Cell. Biol., (20000000), vol. 149, pages 825 - 34
    - GERHART et al., J. Cell. Biol., (20060000), vol. 175, pages 283 - 92
    - GERHART et al., J. Cell. Biol., (20010000), vol. 155, pages 381 - 92
    - STRONY et al., Gene Expr. Patterns, (20050000), vol. 5, pages 387 - 95
    - GERHART et al., J. Cell. Biol., (20040000), vol. 164, pages 739 - 46
    - ASAKURA et al., Dev. Biol., (19950000), vol. 171, pages 386 - 98
    - CHEN et al., Genesis, (20050000), vol. 41, pages 116 - 21
    - GROUNDS et al., Exp. Cell. Res., (19920000), vol. 198, pages 357 - 61
    - GERHART et al., Developmental Biology, (20090000), vol. 336, pages 30 - 41
    - TOMASEK et al., Nat. Rev. Mol. Cell. Biol., (20020000), vol. 3, pages 349 - 63
    - HINZ et al., Am. J. Pathol., (20070000), vol. 170, pages 1807 - 16
    - CATTANEO et al., Nature, (19900000), vol. 347, pages 762 - 5
    - BAI et al., Neuroreport., (20090000), vol. 20, pages 918 - 22
    - HINZ, B., J. Invest. Dermatol., (20070000), vol. 127, pages 526 - 37
    - MAYER et al., J. Cell. Biol., (19970000), vol. 139, pages 1477 - 84
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.